查找临床试验
已按「肌萎缩侧索硬化」检索，对应国际通用词 amyotrophic lateral sclerosis
共找到 12 项正在招募的试验（在中国／港澳台设有中心）
数据更新于 10:03，每 5 分钟自动同步Plasmapheresis in Amyotrophic Lateral Sclerosis With Autoantibody Against NRIP 2 (PALADIN2)
Taiwan
年龄 20 Years – 不限
National Taiwan University Hospital
Clinical Study to Evaluate the Efficacy and Safety of FB1006 in the Treatment of ALS Patients
China
年龄 18 Years – 80 Years
Peking University Third Hospital
The Safety, Tolerability and Preliminary Efficacy of Derived Motor Neuron Progenitor Cells (XS228CN) in Subjects With Amyotrophic Lateral Sclerosis
China
年龄 18 Years – 75 Years
XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd.
China Amyotrophic Lateral Sclerosis Registry of Patients With Traditional Chinese Medicine
China
年龄 18 Years – 不限
Dongzhimen Hospital, Beijing
Clinical Study of Regulatory T Cells (Tregs) in the Treatment of Neurodegenerative Diseases
China
年龄 18 Years – 70 Years
Novabio Therapeutics
Clinical Study of Induced Pluripotent Stem Cells Derived Motor Neuron Precursor Cell Therapy for Amyotrophic Lateral Sclerosis (ALS)
China
年龄 18 Years – 60 Years
Shanghai East Hospital
Natural History and Clinical Features of Amyotrophic Lateral Sclerosis (ALS)
China
年龄 不限 – 不限
Peking University Third Hospital
Research on Wireless Brain Implant System for General Control of External Devices
China
年龄 18 Years – 80 Years
Shanghai StairMed Technology Co., Ltd.
TP04HN106 in the Treatment of Patients With Amyotrophic Lateral Sclerosis
China
年龄 18 Years – 不限
Talengen Institute of Life Sciences, Shenzhen, P.R. China.
Exploring Nasal Drop Therapy With Small Extracellular Vesicles for ALS
China
年龄 18 Years – 80 Years
Xuanwu Hospital, Beijing
A Registered Cohort Study on Amyotrophic Lateral Sclerosis
China
年龄 不限 – 不限
First Affiliated Hospital of Fujian Medical University
A Study to Evaluate the Tolerability, Safety and Efficacy of VGN-R13 in Patients with ALS
China
年龄 18 Years – 不限
Hong Chen